XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment Reporting Information by COVID-19 Charges (Details) - USD ($) $ in Millions | 3 Months Ended | 8 Months Ended
--- | --- | ---
Sep. 04, 2021 | Sep. 05, 2020 | Sep. 04, 2021 | Sep. 05, 2020
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | $ (6) | $ 4 | $ (27) | $ 76
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | (14) | 1 | (19) | 48
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 10 | (1) | 64
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 26 | 62 | 108 | 286
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 13 | 44 | 52 | 130
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | (1) | 26 | 1 | 64
Charges Related to Novel Coronavirus (COVID-19) | 18 | 147 | 114 | 668
Reserve for Product Returns Novel Coronavirus (COVID-19) Impact |  | 3 |  | 19
Social Welfare Credit Novel Coronavirus (COVID-19) Impact |  | 7 |  | 7
Frito Lay North America [Member] |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 0 | (9) | 19
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | 0 | 0 | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 1 | 0 | 8
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 2 | 24 | 31 | 124
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 4 | 16 | 20 | 49
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 1 | 0 | 2 | 3
Charges Related to Novel Coronavirus (COVID-19) | 6 | 41 | 44 | 203
Quaker Foods North America [Member] |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 0 | (1) | 2
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | 0 | 0 | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 0 | 0 | 0
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 0 | 1 | 2 | 7
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 0 | 1 | 1 | 2
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 0 | 1 | 0 | 1
Charges Related to Novel Coronavirus (COVID-19) | (1) | 3 | 2 | 12
PepsiCo Beverages North America [Member] |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (2) | 3 | (15) | 48
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | (13) | 0 | (18) | 46
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 1 | 0 | 30
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 8 | 14 | 27 | 98
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 2 | 12 | 11 | 43
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | (7) | 20 | (15) | 30
Charges Related to Novel Coronavirus (COVID-19) | (12) | 50 | (10) | 295
Latin America (Segment) |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | 0 | 0 | 0 | 1
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | 0 | 0 | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 6 | 1 | 12
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 12 | 19 | 36 | 35
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 4 | 6 | 9 | 14
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 1 | 1 | 3 | 4
Charges Related to Novel Coronavirus (COVID-19) | 17 | 32 | 49 | 66
Europe (Segment) |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 1 | (1) | 5
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | (1) | 1 | (1) | 2
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 0 | 0 | 10
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 2 | 8 | 10 | 17
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 1 | 6 | 7 | 14
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 2 | 0 | 3 | 17
Charges Related to Novel Coronavirus (COVID-19) | 3 | 16 | 18 | 65
Africa, Middle East and South Asia [Member] |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | (1) | 0 | (1) | 1
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | 0 | 0 | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 0 | (2) | 1
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 1 | 1 | 1 | 8
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 2 | 2 | 3 | 6
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 1 | 3 | 4 | 7
Charges Related to Novel Coronavirus (COVID-19) | 3 | 6 | 5 | 23
Asia Pacific, Australia and New Zealand, and China Region [Member] |  |  |  |
Unusual or Infrequent Item, or Both [Line Items] |  |  |  |
Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact | 0 | 0 | 0 | 0
Prepaid Incentives Novel Coronavirus (COVID-19 ) Impact | 0 | 0 | 0 | 0
Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact |  | 2 | 0 | 3
Employee Compensation Expense Novel Coronavirus (COVID-19) Impact | 1 | (5) | 1 | (3)
Employee Protection Costs Novel Coronavirus (COVID-19) Impact | 0 | 1 | 1 | 2
Charges Related to Novel Coronavirus (COVID-19) Impact - Other | 1 | 1 | 4 | 2
Charges Related to Novel Coronavirus (COVID-19) | $ 2 | $ (1) | $ 6 | $ 4

X
- Definition Accounts Receivable, Credit Loss Expense (reversal) Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_AccountsReceivableCreditLossExpensereversalNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Charges Related to Novel Coronavirus (COVID-19) + References No definition available. + Details
Name: | pep_ChargesRelatedtoNovelCoronavirusCOVID19
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Charges Related to Novel Coronavirus (COVID-19) Impact - Other + References No definition available. + Details
Name: | pep_ChargesRelatedtoNovelCoronavirusCOVID19ImpactOther
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Employee Compensation Expense Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_EmployeeCompensationExpenseNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Employee Compensation Costs Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_EmployeeProtectionCostsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Inventory Write-down and Product Returns Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_InventoryWritedownandProductReturnsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Prepaid Incentives Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_PrepaidIncentivesNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Reserve for Product Returns Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_ReserveforProductReturnsNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Social Welfare Credit Novel Coronavirus (COVID-19) Impact + References No definition available. + Details
Name: | pep_SocialWelfareCreditNovelCoronavirusCOVID19Impact
Namespace Prefix: | pep_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_UnusualOrInfrequentItemLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_FritoLayNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_QuakerFoodsNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_PepsiCoBeveragesNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_LatinAmericaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_EuropeSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_AfricaMiddleEastandSouthAsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pep_AsiaPacificAustraliaandNewZealandandChinaRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |